TRELEMA
150MG TBL FLM 56 II
| Maximum ex-factory price/Ex-factory price ? | 2540,33 CZK |
|---|---|
| Legal basis of maximum ex-factory price/ex-factory price ? | Maximum ex-factory price announced under the law. |
Informace o základní úhradě
| Core reimbursement from health insurance ? | 873,92 CZK |
|---|---|
| Maximum reimbursement from health insurance ? | 1193,21 CZK |
| Legal basis of reimbursement from health insurance ? | Reimbursement set by the law. |
| Indication restriction of reimbursement ? | Lakosamid je hrazen pacientům ve věku 16 let a starším k add-on terapii parciálních záchvatů se sekundární generalizací nebo bez ní u epilepsie rezistentní na jiná antiepileptika nebo při nesnášenlivosti jiných antiepileptik. Léčba přípravkem bude ukončena, nedojde-li ke klinicky významnému zlepšení stavu pacienta během třech měsíců terapie. |
| Prescribing doctor's specialisation ? |
Psychiatry, child and adolescent psychiatry, gerontopsychiatry Neurology, children's neurology |
| Reporting limit ? | E: Unless it is advisable to transfer the prescription of the product to another doctor under paragraph 2 in light of the effect and safety of the product, the "E" symbol will mark the product in the decision. |
| Rough price for the final consumer ? | 3359,37 CZK |
| Rough payment for the final consumer (for 1 prescribed package dispensed) ? | 2166.16 CZK |
| Eligible extra payment ? | – |
| Eligible extra payment for individuals aged 65 and older ? | – |
cz